A Randomized, Double-Blind, Placebo-Controlled, Phase 111 Trial of 2 Regimens of Telaprevir (With and Without Delayed. Grant uri icon

Overview

total award amount

  • 119738.00

direct costs

  • 95790.40

sponsor award id

  • VX950-TID24-C216

Background

Time

date/time interval

  • October 10, 2008 - October 6, 2010

Identity

DSR Number

  • 08100801
  • 09021656
  • 09061667
  • 09081063
  • 09081463
  • 09110568
  • 10042857
  • 10072662

PeopleSoft Contract Number

  • 00071001